229 related articles for article (PubMed ID: 8286777)
1. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease.
Baldi E; Burra P; Plebani M; Salvagnini M
Ital J Gastroenterol; 1993 Oct; 25(8):429-32. PubMed ID: 8286777
[TBL] [Abstract][Full Text] [Related]
2. [Serum activity of mitochondrial aspartate aminotransferase and extrahepatic cholestasis].
Hanny P; Ink O; Goenner S; Boutron A; Buffet C
Gastroenterol Clin Biol; 1989 Jan; 13(1):66-70. PubMed ID: 2925044
[TBL] [Abstract][Full Text] [Related]
3. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
4. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.
Eriksen J; Olsen PS; Thomsen AC
Scand J Gastroenterol; 1984 Sep; 19(6):813-9. PubMed ID: 6151242
[TBL] [Abstract][Full Text] [Related]
6. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mAST/tAST ratio as a marker of alcohol misuse in a non-selected population.
Nalpas B; Poupon RE; Vassault A; Hauzanneau P; Sage Y; Schellenberg F; Lacour B; Berthelot P
Alcohol Alcohol; 1989; 24(5):415-9. PubMed ID: 2818750
[TBL] [Abstract][Full Text] [Related]
8. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
9. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
[TBL] [Abstract][Full Text] [Related]
10. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis.
Fletcher LM; Kwoh-Gain I; Powell EE; Powell LW; Halliday JW
Hepatology; 1991 Mar; 13(3):455-9. PubMed ID: 1999316
[TBL] [Abstract][Full Text] [Related]
11. [Malondialdehyde concentration in blood plasma of patients with liver diseases].
Müller G; Rahfeld B; Jannasch M
Z Gesamte Inn Med; 1992 Jun; 47(6):263-5. PubMed ID: 1642026
[TBL] [Abstract][Full Text] [Related]
12. Increased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients.
Yuksel N; Uzbay IT; Karakiliç H; Aki OE; Etik C; Erbaş D
Pharmacopsychiatry; 2005 Mar; 38(2):95-6. PubMed ID: 15744633
[TBL] [Abstract][Full Text] [Related]
13. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.
Başkol M; Başkol G; Deniz K; Ozbakir O; Yücesoy M
Turk J Gastroenterol; 2005 Sep; 16(3):119-23. PubMed ID: 16245219
[TBL] [Abstract][Full Text] [Related]
14. Serum gamma-glutamyltranspeptidase assay in the detection of alcohol consumers and in the early and stadial diagnosis of alcoholic liver disease.
Banciu T; Weidenfeld H; Marcoane E; Berinde L
Med Interne; 1983; 21(1):23-9. PubMed ID: 6133343
[TBL] [Abstract][Full Text] [Related]
15. [The validity of laboratory tests in the diagnosis of alcoholism and alcoholic liver injury].
Rusnák I; Zuffa M; Pullmann R; Lazar V; Benkovic J
Vnitr Lek; 1991 Jun; 37(6):578-84. PubMed ID: 1897140
[TBL] [Abstract][Full Text] [Related]
16. Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease.
Nishimura M; Hasumura Y; Takeuchi J
Gastroenterology; 1980 Apr; 78(4):691-5. PubMed ID: 7353755
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
18. De Ritis ratio as diagnostic marker of alcoholic liver disease.
Majhi S; Baral N; Lamsal M; Mehta KD
Nepal Med Coll J; 2006 Mar; 8(1):40-2. PubMed ID: 16827089
[TBL] [Abstract][Full Text] [Related]
19. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.
Rua RM; Ojeda ML; Nogales F; Rubio JM; Romero-Gómez M; Funuyet J; Murillo ML; Carreras O
Life Sci; 2014 Jan; 94(2):158-63. PubMed ID: 24157457
[TBL] [Abstract][Full Text] [Related]
20. [Relationship among hepatocyte apoptosis, P450 2E1 and oxidative stress in alcoholic liver disease of rats].
Jin WP; Quan XQ; Meng FP; Cui XD; Piao HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):419-21. PubMed ID: 17631711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
